2019 International Congress Archives - Page 6 of 217

1:15pm-2:45pm: Are transventricular approaches associated with increased haemorrhage in functional stereotactic neurosurgery? A comparative study on 550 patients

J. Runge, A. Saryyeva, C. Blahak, C. Schrader, H. Bäzner, HH. Capelle, M. Abdallat, M. Wolf, TM. Kinfe, JK. Krauss (Hannover, Germany)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Are we underestimating the dysautonomic burden in GBA related a-synucleinopathies?

G. Lazzeri, E. Monfrini, I. Trezzi, M. Vizziello, M. Percetti, G. Franco, L. Borellini, A. Arighi, A. Di Fonzo (Milan, Italy)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Arm levitation as an early manifestation in MELAS syndrome: A case report

D. Gunal, I. Midi, E. Erdil (Istanbul, Turkey)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Art du Deplacement (ADD)/Parkour therapy for people with Parkinson’s disease (PDP)

M. Schwed, T. Getrost, K. Torchia, G. Yao (Pfungstadt, Germany)

Non-Pharmacological Interventions · Les Muses Terrace, Level 3

1:15pm-2:45pm: Arterial spin labelling detects subcortical hypoperfusion in early drug-naïve patients with Parkinson’s disease

SP. Caminiti, G. Pagano, G. Dervenoulas, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Assessing the validity and reliability of MANAGE-PD tool to identify patients with Parkinson’s disease inadequately controlled on oral medications – Results from an international survey of general neurologists and movement disorder specialists

A. Antonini, P. Odin, Y. Jalundhwala, P. Schmidt, A. Skalicky, L. Kleinman, J. Zamudio, K. Onuk, P. Kukreja, Y. Bao, F. Cubillos, H. Fernandez (Padua, Italy)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Association between alteration in social cognition and impulse control disorder in Parkinson’s disease

L. Zuazua-Vidal, M. Rodríguez-Violante, R. Solís-Vivanco, A. Pérez-González, A. Alcocer-Salas, A. Cervantes-Arriaga (Mexico City, Mexico)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Association between Parkinson disease and the risk of cardiovascular disease and all-cause mortality: A nationwide, register-based cohort study

DH. Kim, DY. Kwon, MH. Park, KW. Park (Ansan City, Republic of Korea)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Association between sleep disturbances in Parkinson’s disease and bioimaging

M. Nagai, T. Tsujii, R. Ando, Y. Yamanishi, S. Tada, Y. Hosokawa (Ehime, Japan)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Association of active and passive smoking with Parkinson’s disease in women: the E3N cohort study

M. Canonico, F. Artaud, D. Cerasuolo, I. Degaey, P. Gerbouin-Rerolle, A. Kowal, E. Roze, G. Severi, MC. Boutron-Ruault, A. Elbaz (Villejuif, France)

Epidemiology · Les Muses, Level 3